admin

It’s been about two years since Moderna (NASDAQ:MRNA) came public. The company raised $604 million at a $7.5 billion valuation. But the first-day return for MRNA stock was a dud. The return was an awful -19%. Source: Ascannio / Shutterstock.com At the time, there were concerns about the vaccine market, which has traditionally been challenging.
0 Comments
The one constant in the stock markets is change. Said differently, volatility is a constant companion to investors, which is why the CBOE Volatility Index (VIX) is such a widely tracked market index. Ever since this measurement of investor sentiment regarding future volatility was introduced (with futures and options following later), many investors have wondered
0 Comments
Editor’s note: This column is part of InvestorPlace.com’s Best Stocks for 2021 contest. Ben Reynolds’ pick for the contest is Walgreens Boots Alliance (NASDAQ:WBA). Walgreens Boots Alliance (NASDAQ:WBA) is a global pharmacy-led health enterprise, and WBA stock is one of the best to buy for 2021. Source: by InvestorPlace Overall, Walgreens is a large and
0 Comments
There is an old Chinese curse, “May you live in interesting times.” 2020 was certainly an interesting year for investors with holdings in China. Early in 2020, short-sellers went after China as the coronavirus began spreading. However, Chinese markets snapped back quickly, led higher by technology and e-commerce companies, such as Alibaba. Exchange-traded funds (ETFs)
0 Comments
With Wall Street seemingly souring on Palantir (NYSE:PLTR), the company lacking a solid competitive advantage, and the shares continuing to trade at a huge valuation, I remain bearish on Palantir stock. Source: rblfmr / Shutterstock.com In recent weeks, Morgan Stanley and Credit Suisse have dropped Palantir to the equivalent of “sell” ratings. Meanwhile, short-seller  Citron
0 Comments
Editor’s note: This column is part of our Best Stocks for 2021 contest. The Readers’ Choice pick for the contest is Nio (NYSE:NIO). Source: by InvestorPlace Overall, 2020 has provided quite a ride for everyone. And as we look back at the past year, some of the best stocks on Wall Street emerged from the rubble of
0 Comments
It’s been a few weeks since Airbnb (NASDAQ:ABNB) went public at $68 a share. Since then, Airbnb stock has jumped to $150, most of those gains coming on its first day of trading.  Source: BigTunaOnline / Shutterstock.com The short-term stay platform sold $3.74 billion in gross proceeds in its initial public offering. Theoretically, it could
0 Comments
The feasibility of combinations in options trading allows profitable opportunities in varying scenarios. Be it the underlying stock prices going up, going down, or remaining stable, suitably selected option combinations offer apt profit potential.  This article goes over “strip options”, one of the market neutral trading strategies with profit potential on either side of the
0 Comments
In today’s near-zero interest rate environment, it’s been tough for investors looking for yield. There are many high-yielding dividend stocks to buy, but with markets at all-time highs, many of them have gotten stretched when it comes to valuation. With concerns 2020’s overvalued stock market will head lower in 2021, it may not be best
0 Comments
The market’s fixation with drug manufacturers involved in treating or preventing the novel coronavirus is creating opportunities for value investors. Pfizer (NYSE:PFE), through its partnership with BioNTech SE (NASDAQ:BNTX), drew in investor interest. Between November and December, PFE stock traded no lower than $34 and topped around $43. Source: Manuel Esteban / Shutterstock.com Pfizer separated
0 Comments